…18 out 20 patients who received the injection showed the maximum improvement in completing a study designed obstacle course, and 13 completed the task at the lowest level of light needed showing an improvement in vision. None of the patients in the non-therapy comparison group did.
The FDA has until mid January 2018, to make a decision and does not have to follow the recommendation of the panel experts, although often it does.
What do you foresee the FDA deciding? Is curing blindness enough reason to move forward with experimental genetic therapy? Or will the lack of research and knowledge about the side effects of genetic therapy blindside their decision? What are your questions or comments? Let me know. You can post them on Twitter or Facebook using #AskNurseAlice or email them to [email protected].
Nurse Alice is a nationally board-certified and award-winning cardiac clinical nurse specialist and emergency room nurse with nearly two decades of experience in cardiovascular health. She is a community health activist and freelance media health expert. She has appeared on various national radio and TV shows including Dr. Oz, The Doctors, Dr. Drew, News One with Roland Martin, FOX News, KTLA and CNN. She is also the author of “Curb Your Cravings: 31 Foods to Fool Your Appetite.”
You can follow her at AskNurseAlice.com and on Twitter, Facebook, and Instagram at @AskNurseAlice.